Ordonez Claudia

CIK 00018082901 companyLEXINGTON, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001808290

Recent Transactions

25 trades

Exercise/Conversion
Keros Therapeutics, Inc.$KROS
Employee Stock Option (right to buy)
2021-06-11−1,000→ 98,211 total
Exercise/Conversion
Keros Therapeutics, Inc.$KROS
Common Stock
2021-06-11$0.48/sh+1,000→ 1,000 total
Sale
Keros Therapeutics, Inc.$KROS
Common Stock
2021-06-11$50.48/sh−653→ 347 total
Sale
Keros Therapeutics, Inc.$KROS
Common Stock
2021-06-11$51.95/sh−347→ 0 total
Sale
Keros Therapeutics, Inc.$KROS
Common Stock
2021-05-11$50.15/sh−1,000→ 0 total
Exercise/Conversion
Keros Therapeutics, Inc.$KROS
Common Stock
2021-05-11$0.48/sh+1,000→ 1,000 total
Exercise/Conversion
Keros Therapeutics, Inc.$KROS
Employee Stock Option (right to buy)
2021-05-11−1,000→ 99,211 total
Exercise/Conversion
Keros Therapeutics, Inc.$KROS
Common Stock
2021-04-12$0.48/sh+1,000→ 1,000 total
Exercise/Conversion
Keros Therapeutics, Inc.$KROS
Employee Stock Option (right to buy)
2021-04-12−1,000→ 100,211 total
Sale
Keros Therapeutics, Inc.$KROS
Common Stock
2021-04-12$60.01/sh−367→ 233 total
Sale
Keros Therapeutics, Inc.$KROS
Common Stock
2021-04-12$61.23/sh−233→ 0 total
Sale
Keros Therapeutics, Inc.$KROS
Common Stock
2021-04-12$59.09/sh−400→ 600 total
Exercise/Conversion
Keros Therapeutics, Inc.$KROS
Employee Stock Option (right to buy)
2021-03-11−1,000→ 101,211 total
Exercise/Conversion
Keros Therapeutics, Inc.$KROS
Common Stock
2021-03-11$0.48/sh+1,000→ 1,000 total
Sale
Keros Therapeutics, Inc.$KROS
Common Stock
2021-03-11$64.09/sh−395→ 605 total
Sale
Keros Therapeutics, Inc.$KROS
Common Stock
2021-03-11$64.86/sh−605→ 0 total
Sale
Keros Therapeutics, Inc.$KROS
Common Stock
2021-02-11$66.19/sh−295→ 2 total
Exercise/Conversion
Keros Therapeutics, Inc.$KROS
Common Stock
2021-02-11$0.48/sh+1,000→ 1,000 total
Sale
Keros Therapeutics, Inc.$KROS
Common Stock
2021-02-11$68.05/sh−2→ 0 total
Sale
Keros Therapeutics, Inc.$KROS
Common Stock
2021-02-11$65.35/sh−216→ 297 total
Sale
Keros Therapeutics, Inc.$KROS
Common Stock
2021-02-11$63.10/sh−175→ 825 total
Exercise/Conversion
Keros Therapeutics, Inc.$KROS
Employee Stock Option (right to buy)
2021-02-11−1,000→ 102,211 total
Sale
Keros Therapeutics, Inc.$KROS
Common Stock
2021-02-11$64.17/sh−312→ 513 total
Award
Keros Therapeutics, Inc.$KROS
Employee Stock Option (right to buy)
2021-01-10+42,250→ 42,250 total
Award
Keros Therapeutics, Inc.$KROS
Employee Stock Option (right to buy)
2020-04-07+18,430→ 18,430 total

Companies

Keros Therapeutics, Inc.
Chief Medical Officer
$KROS

Recent Filings

Address

C/O KEROS THERAPEUTICS, INC. 99 HAYDEN AVENUE, SUITE 120, BUILDING E

LEXINGTON, MA, 02421

View on SEC.gov